EX-1
from SC 13D/A
1 page
Schedule II Information With Respect to Transactions Effected During the Past Sixty Days or Since the Most Recent Filing on Schedule 13d (1) Shares Purchased Average Date Sold(-) Price(2) Common Stock-Chesapeake Bio Labs Gabelli Associates Ltd 1/09/01 199,550- 4.6000 12/21/00 5,000 4.5000 12/19/00 2,450 4.5000 12/18/00 2,900 4.5000 12/15/00 5,000 4.5000 12/13/00 3,100 4.5000 12/12/00 2,000 4.5000 Gabelli Associates Fund 1/09/01 210,099- 4.6000 12/22/00 1,100 4.5000 12/21/00 1,100 4.5000 12/20/00 1,595 4.5000 12/12/00 3,243 4.5000 (1) the Transactions on 1/09/01 Were in Connection With the Cash Tender Offer Described in Item 5 of This Amendment to Schedule 13d. All Other Transactions Were Effected on the NASDAQ National Market. (2) Price Excludes Commission
12/34/56